젊은 연령에서 발생한 중심망막정맥폐쇄의 임상양상 = Clinical Course of Young Adults With Central Retinal Vein Occlusion

다국어 초록 (Multilingual Abstract)

Purpose: To describe the clinical course of young patients with central retinal vein occlusion (CRVO). Methods: We reviewed the records of patients 50 years or younger who presented with CRVO and who were followed up for at least 6 months. Results: The average age of the patients was 37.7 years, and the mean follow-up time was 26.3 months. Participants included 27 patients with CRVO younger than 50 years among the total 393 patients with CRVO, and the sex distribution was nearly equal; 13 patients were male and 14 patients were female. Associated systemic diseases were hypertension (8 patients), diabetes (3 patients), stroke (3 patients), and myocardial infarction (1 patient). Of the 17 patients who had no systemic disease, 8 patients had hypercholesterolemia or another hematologic abnormalities. Of the 18 eyes with non-ischemic CRVO, 10 eyes (55.6%) showed improved final visual acuities (2 or more lines). Of the 9 eyes with ischemic CRVO, only 1 eye (11.1%) showed improved visual acuity. Conclusions: Hematological examination and treatment with systemic evaluation were recommended to younger patients with CRVO. The classification of retinal ischemia of young patients as well as that of older patients could be useful for the follow-up of patients and the assessment of its progression in the future.

참고문헌 (Reference)

1 "The eye disease case-control study group. Risk factors for central retinal vein occlusion" 114 : 545-554, 1996

2 "The central vein occlusion study group. Baseline and early natural history report" 111 : 1087-1095, 1993

3 "The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion" 115 : 486-491, 1997

4 Klien BA, "Sidelights on retinal venous occlusion" 61 : 25-36, 1966

5 Chen V, "Severe ischemic process in a young man with CRVO" 11 : 67-69, 1988

6 Magargal LE, "Retinal ischemia and risk of neovascularization following central retinal vein destruction" 89 : 1241-1245, 1982

7 Ministry of Welfare, "Report on 2005 national health and nutrition survey" Ministry of Health and Welfare 103-130, 2007

8 Priluck IA, "Long-term follow-up of occlusion of the central retinal vein in young adults" 90 : 190-202, 1980

9 Lahey JM, "Laboratory evaluation of hypercoagulable state in patients with central retinal vein occlusion who are less than 56 years of age" 109 : 126-131, 2002

10 Bandello F, "Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion" 72 : 39-43, 1994

11 Hayreh SS, "Hematologic abnormalities associated with various type of retinal vein occlusion" 240 : 180-196, 2002

12 Gutman FA, "Evaluation of a patient with central retinal vein occlusion" 90 : 481-483, 1983

13 Green WR, "Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases" 1 : 27-55, 1981

14 Fong AC, "Central retinal vein occlusion in young adults" 37 : 393-417, 1993

15 Fong AC, "Central retinal vein occlusion in young adult (papillophlebitis)" 12 : 3-11, 1992

16 Walters RF, "Central retinal vein occlusion in people aged 40 years or less: a review of 17 patients" 74 : 30-35, 1990

17 Adamczuk YP, "Central retinal vein occlusion and thrombophilia risk factors" 13 : 623-626, 2002

18 Magargal LE, "Central retinal vein obstruction in the young adult" 37 : 148-153, 1985

19 Klien BA, "A survey of the pathogenesis of retinal venous occlusion. Emphasis upon choice of therapy and an analysis of the therapeutic results in fifty-three patients" 56 : 207-247, 1956